CCCC Financial Statements

Balance sheet, income statement, cash flow, and dividends for C4 Therapeutics Inc (CCCC).


$254.12M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

CCCC Market Cap. (MRY)


CCCC Shares Outstanding (MRY)


CCCC Assets (MRY)


Total Assets

$349.60M

Total Liabilities

$133.62M

Total Investments

$211.76M

CCCC Income (MRY)


Revenue

$35.58M

Net Income

-$105.32M

Operating Expense

$155.20M

CCCC Cash Flow (MRY)


CF Operations

-$65.16M

CF Investing

-$51.27M

CF Financing

$45.34M

CCCC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CCCC Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$349,602,000 (-7.13%)

$376,451,000 (-12.62%)

$430,840,000 (-14.98%)

$506,765,000 (26.65%)

Assets Current

$257,767,000 (-4.95%)

$271,189,000 (-5.69%)

$287,557,000 (-11.71%)

$325,689,000 (-14.52%)

Assets Non-Current

$91,835,000 (-12.76%)

$105,262,000 (-26.54%)

$143,283,000 (-20.87%)

$181,076,000 (846.60%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$215,986,000 (-12.24%)

$246,114,000 (-14.91%)

$289,234,000 (-25.76%)

$389,606,000 (38.75%)

Property Plant & Equipment Net

$63,378,000 (-10.85%)

$71,088,000 (-8.29%)

$77,516,000 (121.14%)

$35,053,000 (111.78%)

Cash & Equivalents

$58,942,000 (-54.67%)

$130,033,000 (293.65%)

$33,033,000 (-58.40%)

$79,403,000 (-56.92%)

Accumulated Other Comprehensive Income

$53,000 (141.73%)

-$127,000 (96.93%)

-$4,137,000 (-433.81%)

-$775,000 (-6061.54%)

Deferred Revenue

$47,169,000 (26.51%)

$37,285,000 (11.26%)

$33,513,000 (-40.33%)

$56,168,000 (-30.84%)

Total Investments

$211,764,000 (36.53%)

$155,099,000 (-49.54%)

$307,361,000 (-18.11%)

$375,355,000 (97.59%)

Investments Current

$189,405,000 (49.03%)

$127,091,000 (-48.42%)

$246,399,000 (5.68%)

$233,155,000 (22.74%)

Investments Non-Current

$22,359,000 (-20.17%)

$28,008,000 (-54.06%)

$60,962,000 (-57.13%)

$142,200,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,102,000 (-73.71%)

$11,799,000 (701.02%)

$1,473,000 (-74.23%)

$5,716,000 (27.48%)

Trade & Non-Trade Payables

$1,328,000 (-8.16%)

$1,446,000 (23.38%)

$1,172,000 (-73.99%)

$4,506,000 (-20.71%)

Accumulated Retained Earnings (Deficit)

-$633,699,000 (-19.93%)

-$528,383,000 (-33.47%)

-$395,890,000 (-47.88%)

-$267,715,000 (-45.64%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$65,756,000 (-7.35%)

$70,976,000 (-18.56%)

$87,152,000 (103.25%)

$42,879,000 (87.08%)

Debt Current

$5,774,000 (10.63%)

$5,219,000 (-25.30%)

$6,987,000 (423.76%)

$1,334,000 (28.02%)

Debt Non-Current

$59,982,000 (-8.78%)

$65,757,000 (-17.97%)

$80,165,000 (92.96%)

$41,545,000 (89.89%)

Total Liabilities

$133,616,000 (2.52%)

$130,337,000 (-7.96%)

$141,606,000 (20.87%)

$117,159,000 (-1.83%)

Liabilities Current

$45,177,000 (5.64%)

$42,766,000 (-4.00%)

$44,546,000 (-13.07%)

$51,246,000 (16.86%)

Liabilities Non-Current

$88,439,000 (0.99%)

$87,571,000 (-9.78%)

$97,060,000 (47.25%)

$65,913,000 (-12.69%)

CCCC Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$35,584,000 (71.44%)

$20,756,000 (-33.25%)

$31,096,000 (-32.08%)

$45,785,000 (37.93%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$42,124,000 (0.10%)

$42,081,000 (-1.65%)

$42,789,000 (28.67%)

$33,254,000 (118.72%)

Research & Development Expense

$110,637,000 (-6.01%)

$117,706,000 (-0.11%)

$117,841,000 (24.48%)

$94,665,000 (20.68%)

Operating Expenses

$155,198,000 (-2.87%)

$159,787,000 (-0.52%)

$160,630,000 (25.57%)

$127,919,000 (36.60%)

Interest Expense

$0 (0%)

$1,373,000 (-38.04%)

$2,216,000 (3.31%)

$2,145,000 (74.53%)

Income Tax Expense

$131,000 (-89.77%)

$1,280,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$105,316,000 (20.51%)

-$132,493,000 (-3.37%)

-$128,175,000 (-52.79%)

-$83,892,000 (-26.47%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$105,316,000 (20.51%)

-$132,493,000 (-3.37%)

-$128,175,000 (-52.79%)

-$83,892,000 (-26.47%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$105,316,000 (20.51%)

-$132,493,000 (-3.37%)

-$128,175,000 (-52.79%)

-$83,892,000 (-26.47%)

Weighted Average Shares

$69,372,993 (39.75%)

$49,640,505 (1.59%)

$48,861,665 (6.12%)

$46,041,733 (304.93%)

Weighted Average Shares Diluted

$69,372,993 (39.75%)

$49,640,505 (1.59%)

$48,861,665 (6.12%)

$46,041,733 (304.93%)

Earning Before Interest & Taxes (EBIT)

-$105,185,000 (18.99%)

-$129,840,000 (-3.08%)

-$125,959,000 (-54.08%)

-$81,747,000 (-24.36%)

Gross Profit

$35,584,000 (71.44%)

$20,756,000 (-33.25%)

$31,096,000 (-32.08%)

$45,785,000 (37.93%)

Operating Income

-$119,614,000 (13.97%)

-$139,031,000 (-7.33%)

-$129,534,000 (-57.71%)

-$82,134,000 (-35.87%)

CCCC Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$51,270,000 (-132.38%)

$158,349,000 (171.04%)

$58,422,000 (130.86%)

-$189,336,000 (0.61%)

Net Cash Flow from Financing

$45,336,000 (-0.34%)

$45,489,000 (3865.91%)

$1,147,000 (-99.33%)

$171,400,000 (-50.88%)

Net Cash Flow from Operations

-$65,157,000 (39.01%)

-$106,838,000 (-0.85%)

-$105,939,000 (-21.82%)

-$86,965,000 (-29.32%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$71,091,000 (-173.29%)

$97,000,000 (309.19%)

-$46,370,000 (55.80%)

-$104,901,000 (-215.05%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$51,090,000 (-131.92%)

$160,057,000 (150.41%)

$63,918,000 (133.99%)

-$188,059,000 (0.95%)

Capital Expenditure

-$180,000 (89.46%)

-$1,708,000 (68.92%)

-$5,496,000 (-330.38%)

-$1,277,000 (-96.46%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$12,500,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$44,954,000 (-21.98%)

$57,621,000 (7315.83%)

$777,000 (-99.55%)

$171,509,000 (-10.75%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$29,662,000 (8.91%)

$27,235,000 (-9.27%)

$30,016,000 (39.53%)

$21,512,000 (526.81%)

Depreciation Amortization & Accretion

$8,239,000 (2.49%)

$8,039,000 (6.17%)

$7,572,000 (160.47%)

$2,907,000 (2.32%)

CCCC Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-296.00% (53.63%)

-638.30% (-54.85%)

-412.20% (-125.00%)

-183.20% (8.31%)

EBITDA Margin

-272.40% (53.58%)

-586.80% (-54.14%)

-380.70% (-121.08%)

-172.20% (9.13%)

Return on Average Equity (ROAE)

-43.70% (20.98%)

-55.30% (-42.16%)

-38.90% (-69.87%)

-22.90% (70.87%)

Return on Average Assets (ROAA)

-28.00% (21.79%)

-35.80% (-32.59%)

-27.00% (-54.29%)

-17.50% (31.64%)

Return on Sales (ROS)

-295.60% (52.75%)

-625.60% (-54.43%)

-405.10% (-126.95%)

-178.50% (9.85%)

Return on Invested Capital (ROIC)

-32.70% (15.94%)

-38.90% (-44.61%)

-26.90% (-0.75%)

-26.70% (59.36%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.37 (-11.91%)

-2.12 (6.04%)

-2.25 (87.27%)

-17.69 (-211.31%)

Price to Sales Ratio (P/S)

7.02 (-48.06%)

13.51 (45.76%)

9.27 (-71.37%)

32.38 (185.35%)

Price to Book Ratio (P/B)

1.18 (4.07%)

1.13 (13.21%)

1 (-75.14%)

4.02 (-20.84%)

Debt to Equity Ratio (D/E)

0.62 (16.79%)

0.53 (8.16%)

0.49 (62.79%)

0.3 (-29.18%)

Earnings Per Share (EPS)

-1.52 (43.07%)

-2.67 (-1.91%)

-2.62 (-43.96%)

-1.82 (68.78%)

Sales Per Share (SPS)

0.51 (22.73%)

0.42 (-34.28%)

0.64 (-36.02%)

0.99 (-65.95%)

Free Cash Flow Per Share (FCFPS)

-0.94 (56.93%)

-2.19 (4.12%)

-2.28 (-18.99%)

-1.92 (67.90%)

Book Value Per Share (BVPS)

3.11 (-37.21%)

4.96 (-16.24%)

5.92 (-30.05%)

8.46 (-65.73%)

Tangible Assets Book Value Per Share (TABVPS)

5.04 (-33.56%)

7.58 (-13.99%)

8.82 (-19.89%)

11.01 (-68.72%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0.00%)

-2 (33.33%)

-3 (82.35%)

-17 (19.05%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.66 (-13.32%)

-2.35 (14.14%)

-2.74 (84.85%)

-18.07 (17.81%)

Asset Turnover

0.1 (69.64%)

0.06 (-13.85%)

0.07 (-32.29%)

0.1 (-25.00%)

Current Ratio

5.71 (-10.01%)

6.34 (-1.77%)

6.46 (1.57%)

6.36 (-26.86%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$65,337,000 (39.81%)

-$108,546,000 (2.59%)

-$111,435,000 (-26.28%)

-$88,242,000 (-29.96%)

Enterprise Value (EV)

$258,123,252 (-9.81%)

$286,194,910 (-11.69%)

$324,071,341 (-77.25%)

$1,424,408,578 (3.03%)

Earnings Before Tax (EBT)

-$105,185,000 (19.84%)

-$131,213,000 (-2.37%)

-$128,175,000 (-52.79%)

-$83,892,000 (-25.28%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$96,946,000 (20.41%)

-$121,801,000 (-2.88%)

-$118,387,000 (-50.16%)

-$78,840,000 (-25.36%)

Invested Capital

$311,239,000 (13.33%)

$274,628,000 (-37.64%)

$440,413,000 (5.11%)

$418,995,000 (114.98%)

Working Capital

$212,590,000 (-6.93%)

$228,423,000 (-6.00%)

$243,011,000 (-11.45%)

$274,443,000 (-18.60%)

Tangible Asset Value

$349,602,000 (-7.13%)

$376,451,000 (-12.62%)

$430,840,000 (-14.98%)

$506,765,000 (26.65%)

Market Capitalization

$254,120,252 (-8.73%)

$278,437,910 (-3.60%)

$288,846,341 (-81.55%)

$1,565,744,578 (9.83%)

Average Equity

$240,995,500 (0.59%)

$239,578,750 (-27.21%)

$329,133,750 (-10.35%)

$367,129,500 (334.92%)

Average Assets

$376,281,500 (1.66%)

$370,127,000 (-22.09%)

$475,059,750 (-0.88%)

$479,276,000 (84.91%)

Invested Capital Average

$321,683,000 (-3.75%)

$334,200,000 (-28.53%)

$467,629,500 (52.92%)

$305,800,000 (205.58%)

Shares

70,588,959 (43.24%)

49,281,046 (0.66%)

48,957,007 (0.68%)

48,625,608 (13.01%)